Propofol in a modified cyclodextrin formulation: first human study of dose-response with emphasis on injection pain.

BACKGROUND:A new lipid-free preparation of propofol has been developed containing the drug, sulfobutylether s-cyclodextrin and water. The primary objective of this study was to compare the effects of propofol in the lipid formulation with those of the new cyclodextrin formulation, particularly with